Excerpt · Fox News — Latest
The U.S. Food and Drug Administration approved the use of a new cancer treatment pill Wednesday. Rasonque, manufactured by Revolution Medicines in California, is an inhibitor for the most common type of pancreatic cancer . The tablet, which is taken once daily, targets multiple forms of a protein called RAS that…
We haven't published a neutral rewrite of this one, so we don't reproduce the original in full — the reporting belongs to Fox News — Latest. You can still compare how outlets framed this story below.